The role of nuclear factor kappa B in lens epithelial cell proliferation using a capsular bag model

Ophthalmic Research

Volumn 40, Issue 5, 2008, Pages 273-278

  Lee, Seok Jong ^a   Bae, Sangwoo ^a   Seomun, Young ^a   Son, Min Jung ^a   Joo, Choun Ki ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Capsular bag model; Cataract; Lens epithelial cell; Nuclear factor B; Posterior capsular opacification

Indexed keywords

CARBON DIOXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SALAZOSULFAPYRIDINE; SN 50;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; EYE; IMMUNOHISTOCHEMISTRY; LENS; MICROSCOPY; MODEL; NONHUMAN; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CATARACT; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; EPITHELIAL CELLS; IMMUNOHISTOCHEMISTRY; LENS CAPSULE, CRYSTALLINE; LENS, CRYSTALLINE; MICROSCOPY, ELECTRON, SCANNING; MODELS, BIOLOGICAL; NF-KAPPA B; PEPTIDES; SULFASALAZINE; SWINE;

EID: 50049108764     PISSN: 00303747     EISSN: None     Source Type: Journal    
DOI: 10.1159/000128162     Document Type: Article

References (25)

1. Neumayer T, Findl O, Buehl W, Sacu S, Menapace R, Georgopoulos M: Long-term changes in the morphology of posterior capsule opacification. J Cataract Refract Surg 2005;31:2120-2128.
2. Dewey S: Posterior capsule opacification. Curr Opin Ophthalmol 2006;17:45-53.
3. Marcantonio JM, Vrensen GF: Cell biology of posterior capsular opacification. Eye 1999;13:484-488.
4. Kappelhof JP, Vrensen GFJM, de Jong PTVM, Pameyer J, Willekens B: An ultrastructural study of Elschnig's pearls in the pseudophakic eye. Am J Ophthalmol 1986;101:58-69.
5. Kappelhof JP, Vrensen GFJM, de Jong PTVM, Pameyer J, Willekens BLJC: The ring of Soemmerring in man: an ultrastructural study. Graefes Arch Clin Exp Ophthalmol 1987;225:77-83.
6. Rakic JM, Galand A, Vrensen GF: Lens epithelial cell proliferation in human posterior capsule opacification specimens. Exp Eye Res 2000;71:489-494.
7. Liu CS, Wormstone IM, Duncan G: A study of human lens cell growth in vitro: a model for posterior capsule opacification. Invest Ophthalmol Vis Sci 1996;37:906-914.
8. Wormstone IM, Liu CS, Rakic JM: Human lens epithelial cell proliferation in a protein-free medium. Invest Ophthalmol Vis Sci 1997;38:396-404.
9. Saika S, Kawashima Y, Miyamoto T: Immunolocalization of prolyl 4-hydroxylase subunits, α-smooth muscle actin and extracellular matrix components in human lens capsules with lens implants. Exp Eye Res 1998;66:283-294.
10. Saika S, Yamanaka A, Tanaki S-I, Ohmi S, Ohnishi Y, Coshima A: Extracellular matrix on intraocular lenses. Exp Eye Res 1995;61:713-721.
11. Odrich MG, Hall SJ, Worgul BV, Trokel SL, Rini FJ: Posterior capsule opacification: experimental analyses. Ophthalmic Res 1985;17:75-84.
12. Cobo LM, Ohsawa E, Chandler D, Arguello R, George G: Pathogenesis of capsular opacification after extracapsular cataract extraction: an animal model. Ophthalmology 1984;91:857-863.
13. Saxby L, Rosen E, Boulton M: Lens epithelial cell proliferation, migration, and metaplasia following capsulorhexis. Br J Ophthalmol 1998;82:945-952.
14. Duncan G, Wormstone IM, Liu CS, Marcantonio JM, Davies PD: Thapsigargin-coated intraocular lenses inhibit human lens cell growth. Nat Med 1997;3:1026-1028.
15. Wormstone IM, Tamiya S, Anderson I, Duncan G: TGF-beta2-induced matrix modification and cell transdifferentiation in the human lens capsular bag. Invest Ophthalmol Vis Sci 2002;43:2301-2308.
16. Shishodia S, Aggarwal BB: Nuclear factor-kappaB activation: a question of life or death. J Biochem Mol Biol: 2002;35:28-40.
17. Ren H, Schmalstieg A, Yuan D, Gaynor RB: I-kappa B kinase beta is critical for B cell proliferation and antibody response. J Immunol 2002;168:577-587.
18. Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM: Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb. Nature 1998;392:611-614.
19. Dejardin E, Bonizzi G, Bellahcene A, Castronovo V, Merville MP, Bours V: Highly-expressed p100/p52 (NF-κB2) sequesters other NF-kappa B-related proteins in the cytoplasm of human breast cancer cells. Oncogene 1995;11:1835-1841.
20. Sovak MA, Bellas RE, Kim DW, Zanieski GJ, Rogers AE, Traish AM, Sonenshein GE: Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. J Clin Invest 1997;100:2952-2960.
21. Muller M, Morotti A, Ponzetto C: Activation of NF-kappaB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis. Mol Cell Biol 2002;22:1060-1072.
22. Finco TS, Westwick JK, Norris JL, Beg AA, Der CJ, Baldwin AS Jr: Oncogenic Ha-Ras-induced signaling activates NF-kappaB transcriptional activity, which is required for cellular transformation. J Biol Chem 1997;272:24113- 24116.
23. Liang Y, Zhou Y, Shen P: NF-kappaB and its regulation on the immune system. Cell Mol Immunol 2004;1:343-350.
24. Adcock IM, Cosio B, Tsaprouni L, Barnes PJ, Ito K: Redox regulation of histone deacetylases and glucocorticoid-mediated inhibition of the inflammatory response. Antioxid Redox Signal 2005;7:144-152.
25. Luo JL, Kamata H, Karin M: IKK/NF-kappaB signaling: balancing life and death - a new approach to cancer therapy. J Clin Invest 2005;115: 2625-2632.